Does lipoprotein(a) impair endothelial function?

Journal of the American College of Cardiology

Volumn 31, Issue 2, 1998, Pages 359-365

  Schlaich, Markus P ^a   John, Stefan ^a   Langenfeld, Matthias R W ^a   Lackner, Karl J ^b   Schmitz, Gerd ^b   Schmieder, Roland E ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

LIPOPROTEIN A; NITROPRUSSIDE SODIUM;

ANGIOCARDIOGRAPHY; ARTICLE; ATHEROGENESIS; BLOOD VESSEL REACTIVITY; BODY MASS; CARDIOVASCULAR RESPONSE; CELL FUNCTION; CORONARY RISK; ENDOTHELIUM CELL; FOREARM BLOOD FLOW; HUMAN; HUMAN CELL; HYPERCHOLESTEROLEMIA; LIPOPROTEIN METABOLISM; PRIORITY JOURNAL; REGRESSION ANALYSIS;

ACETYLCHOLINE; ADULT; ARTERIOSCLEROSIS; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CORONARY DISEASE; ENDOTHELIUM, VASCULAR; ENZYME INHIBITORS; FEMALE; FOREARM; HUMANS; IMMUNOELECTROPHORESIS; INFUSIONS, INTRA-ARTERIAL; LIPOPROTEIN(A); MALE; MIDDLE AGED; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITROPRUSSIDE; OMEGA-N-METHYLARGININE; PLETHYSMOGRAPHY; REGIONAL BLOOD FLOW; REGRESSION ANALYSIS; RISK FACTORS; VASOCONSTRICTOR AGENTS; VASODILATION; VASODILATOR AGENTS;

EID: 0031966827     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(97)00497-X     Document Type: Article

References (35)

1. Sandkamp M, Funke H, Shulute H, Köhler E, Assmann G. Lipoprotein(a) is an independent risk factor for myocardial infarction at young age. Clin Chem. 36:1990;20-23.
2. Rosengren A, Wilhemsen L, Eriksson E, Risberg B, Wedel H. Lipoprotein(a) and coronary heart disease a prospective case-control study in a general population sample of middle aged men . Br Med J. 301:1990;1248-1251.
3. Rhoads GG, Dahlen G, Berg K, Morton NE, Dannenberg AL. Lp(a) lipoprotein as a risk factor for myocardial infarction. JAMA. 256:1986;2540-2544.
4. Dahlen GH, Guyton JR, Attar M, Farmer JA, Kautz JA, Gotto AM. Association of levels of lipoprotein(a), plasma lipids, and other lipoproteins with coronary artery disease documented by angiography. Circulation. 74:1986;758-765.
5. Assman G, Schulte H, von Eckardstein A. Hypertriglyceridemia and elevated lipoprotein(a) are risk factors for major coronary events in middle-aged men. Am J Cardiol. 77:1996;1179-1184.
6. Zeiher AM, Drexler H, Saurbier B, Just H. Endothelium-mediated coronary blood flow modulation in humans effects of age, atherosclerosis, hypercholesteremia and hypertension . J Clin Invest. 92:1993;652-662.
7. Zeiher AM, Schächinger V, Minners J. Long-term cigarette smoking impairs endothelium dependent coronary arterial vasodilator function. Circulation. 92:1995;1094-1100.
8. Vita JA, Treasure CB, Nabel EG. Coronary vasomotor response to acetylcholine relates to risk factors for coronary heart disease. Circulation. 81:1990;491-497.
9. Reddy KJ, Nair R, Sheehan HM, Hodgson JM. Evidence that selective endothelial dysfunction may occur in the absence of angiographic or ultrasound atherosclerosis in patients with risk factors for atherosclerosis. J Am Coll Cardiol. 89:1994;1615-1623.
10. Zeiher AM, Drexler H, Wollschläger H, Just H. Endothelial dysfunction of the coronary microvasculature is associated with coronary blood flow regulation in patients with early atherosclerosis. Circulation. 84:1991;1984-1992.
11. Zeiher AM, Schachinger V, Hohnloser SH, Saurbier B, Just H. Coronary atherosclerotic wall thickening and vascular reactivity in humans elevated high-density lipoprotein levels ameliorate abnormal vasoconstriction in early atherosclerosis . Circulation. 89:1994;2525-2532.
12. Zenker G, Körtringer P, Bone G, Niederkorn K, Pfeiffer K, Jürgens G. Lipoprotein(a) as a strong indicator for cerebrovascular disease. Stroke. 17:1986;942-945.
13. Jürgens G, Körtringer P. Lipoprotein(a) in ischemic cerebrovascular disease a new approach to the assessment of risk for stroke . Neurology. 37:1987;513-515.
14. Baldassarre D, Tremoli E, Franceschini G, Michelagnoli S, Sirtori CR. Plasma lipoprotein(a) is an independent factor associated with carotid wall thickening in severely but not moderately hypercholesterolemic patients. Stroke. 27:1996;1044-1049.
15. Kronenberg F, Utermann G, Dieplinger H. Lipoprotein(a) in renal disease. Am J Kidney Dis. 27:1996;1-25.
16. Feely J, Barry M, Keeling BWM, Weir DG, Cooke T. Lipoprotein(a) in cirrhosis. Br Med J. 304:1992;545-546.
17. Nago N, Kayaba K, Hiraoka J, et al. Lipoprotein(a) levels in the Japanese population influence of age and sex, and relation to atherosclerotic risk factors. The Jichi Medical School Cohort Study . Am J Epidemiol. 141:1995;815-821.
18. Jenner JL, Ordovas JM, Lamon-Fava S. Effects of age, sex, and menopausal status on plasma lipoprotein(a) levels the Framingham Offspring Study . Circulation. 87:1993;1135-1141.
19. Liu AC, Lawn RM. Vascular interactions of lipoprotein(a). Curr Opin Lipidol. 5:1994;269-274.
20. Chowienczyk PJ, Watts GF, Cockkroft JR, Ritte JM. Impaired endothelium-dependent vasodilation of forearm resistance vessels in hypercholesterolaemia. Lancet. 340:1992;1430-1432.
21. Leung WH, Lau CP, Wong CK. Beneficial effect of cholesterol-lowering therapy on coronary endothelium-dependent relaxation in hypercholesterolaemic patients. Lancet. 341:1993;1496-1500.
22. Anderson TJ, Uehata A, Gerhard MD, et al. Close relationship of endothelial function in the coronary and peripheral circulations. J Am Coll Cardiol. 26:1995;1235-1241.
23. Lipid Research Clinic Program. Lipid and Lipoprotein Analysis: Manual of Laboratory Operations. US Dept. Of Health, Education, and Welfare publication NIH/75-628. Washington (DC): US Government Printing Office; 1982.
24. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low density lipoprotein cholesterol in plasma, without use of preparative ultracentrifuge. Clin Chem. 18:1972;499-502.
25. Benjamin N, Calver A, Collier J, Robinson B, Vallance P, Webb D. Measuring forearm blood flow and interpreting the responses to drugs and mediators. Hypertension. 25:1995;918-923.
26. Calver A, Collier J, Vallance P. Inhibition and stimulation of nitric oxide synthesis in the human forearm arterial bed of patients with insulin-dependent diabetes. J Clin Invest. 90:1992;2548-2554.
27. Sudhir K, Jennings G, Funder JW, Komsearoff PA. Estrogen enhances basal nitric oxide release in the forearm vasculature in perimenopausal women. Hypertension. 28:1996;330-334.
28. Hayashi T, Fukuto JM, Ignarro LJ, Chaudhuri G. Basal release of nitric oxide from aortic rings is greater in female rabbits than in male rabbits implications for atherosclerosis . Proc Natl Acad Sci U S A. 89:1992;1259-1263.
29. Schlaich MP, John S, Weihprecht H, Schmieder RE. Nitric oxide bioactivity in premenopausal women on hormonal contraceptives [abstract]. Atherosclerosis 1997;134:2.P.312; S. 181.
30. McVeigh GE, Lemay L, Morgan D, Cohn DJ. Effects of long-term cigarette smoking on endothelium-dependent response in humans. Am J Cardiol. 78:1996;668-672.
31. Tsurumi Y, Nagashima H, Ichikawa K, Sumiyoshi T, Hosoda S. Influence of plasma lipoprotein(a) levels on coronary vasomotor response to acetylcholine. J Am Coll Cardiol. 26:1995;1242-1250.
32. Sorensen KE, Celermajer DS, Georgakopolous D, Hatcher G, Betteridge DJ, Deanfield JE. Impairment of endothelium dependent dilation is an early event in children with familial hypercholesterolemia and is related to the lipoprotein(a) level. J Clin Invest. 93:1994;50-55.
33. Vane JR, Anggard EE, Botting RM. Regulatory functions of the vascular endothelium. N Engl J Med. 323:1990;27-36.
34. Davisson RL, Bates JN, Johnson AK, Lewis SJ. Use dependent loss of acetylcholine- and bradykinin-mediated vasodilation after nitric oxide synthase inhibition evidence for preformed stores of nitric oxide-containing factors in vascular endothelial cells . Hypertension. 28:1996;354-360.
35. Ignarro LJ. Nitric oxide a novel signal transduction mechanism for transcellular communication . Hypertension. 16:1990;477-483.